The association between metabolic syndrome and coronary artery disease in Jordan

Abstract

Background: Previous studies in Jordan showed a considerably high prevalence of metabolic syndrome (MeS) and its individual components. However, data about the association between MeS and coronary artery disease (CAD) in Jordan are lacking. Therefore, this study aimed to determine the association between MeS and CAD among Jordanians.

Methods: This case-control study included 269 patients diagnosed with CAD and 1026 subjects without CAD. Data collected from cases and controls included socio-demographic and clinical characteristics and anthropometric measurements. Patients were diagnosed with MeS based on the criteria of the National Cholesterol Education Program (NCEP) adult treatment panel (ATP) III.

Results: MeS was present in 65.1% of patients with CAD and in 44.0% of those with no CAD (p<0.0005). After adjusting for the important variables in the multivariate analysis, those with MeS were twice more likely to have CAD (OR = 1.94, 95% CI: 1.29, 2.93, p = 0.002) compared to those without MeS. The number of metabolic abnormalities was significantly associated with CAD, when it substituted MeS in the regression model, with a higher number of MeS components led to greater odds for CAD.

Conclusions: The MeS, which occurs very frequently in the general population, is associated with CAD in Jordan. The identification of subjects with the MeS is conceivably useful from a clinical standpoint, as it can be anticipated that these individuals should benefit from interventions aimed at reducing cardiovascular risk.

Keywords

Case-control study Coronary artery disease Jordan Metabolic syndrome

Get full access to this article

View all access options for this article.

References

Hunt KJ , Resendez RG , Williams K. , Haffner SM , Stern MP National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004 ; 110: 1251-7.

Girman CJ , Rhodes T. , Mercuri M. , et al. The metabolic syndrome and risk of major coronary events in the Scandinavian, Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/ TexCAPS). Am J Cardiol 2004; 93: 136-41.

Ford ES The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004; 173: 309-14.

Malik S. , Wong ND , Franklin SS , et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults . Circulation 2004; 110: 1245-50.

Lawlor DA , Smith GD , Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women’s Heart and Health Study. Diabetologia 2006; 49: 41-8.

Dekker JM , Girman C. , Rhodes T. , et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005; 112: 666-73.

Sattar N. , Gaw A. , Scherbakova O. , et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-9.

Lakka HM , Laaksonen DE , Lakka TA , et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16.

Isomaa B. , Almgren P. , Tuomi T. , et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.

10.

Hong Y. , Jin X. , Mo J. , et al. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality-results of prospective analysis for the Atherosclerosis Risk in Communities study. J Intern Med 2007; 262: 113-22.

11.

Milionis HJ , Kalantzi KJ , Papathanasiou AJ , Kosovitsas AA , Doumas MT , Goudevenos JA Metabolic syndrome and risk of acute coronary syndromes in patients younger than 45 years of age. Coron Artery Dis 2007; 18: 247-52.

12.

Zornitzki T. , Ayzenberg O. , Gandelman G. , et al. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women. QJM 2007; 100: 575-81.

13.

Wang JJ , Li HB , Kinnunen L. , et al. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population? Atherosclerosis 2007; 192: 161-8.

14.

Wierzbicki AS , Nishtar S. , Lumb PJ , et al. Metabolic syndrome and risk of coronary heart disease in a Pakistani cohort. Heart 2005; 91: 1003-7.

15.

Iribarren C. , Go AS , Husson G. , et al. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? J Am Coll Cardiol 2006; 48: 1800-7.

16.

Lawlor DA , Ebrahim S. , Davey Smith G. The metabolic syndrome and coronary heart disease in older women: findings from the British Women’s Heart and Health Study. Diabet Med 2004; 21: 906-13.

17.

Khader Y. , Bateiha A. , El-Khateeb M. , Al- Shaikh A. , Ajlouni K. High prevalence of the metabolic syndrome among Northern Jordanians . J Diabetes Complications 2007; 21: 214-9.

18.

Ajlouni K. , Khader YS , Batieha A. , Ajlouni H. , El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years . J Diabetes Complications 2008; 22: 317-24.

19.

Khader Y. , Batieha A. , Ajlouni H. , El-Khateeb M. , Ajlouni K. Obesity in Jordan: prevalence, associated factors, comorbidities, and change in prevalence over ten years. Metab Syndr Relat Disord 2008; 6: 113-20.

20.

Khader Y. , Khatatbeh M. , El- Salem K. , Amarin Z. , Bateiha A. The metabolic syndrome among patients undergoing cardiac catheterization in Jordan. J Cardiometab Syndr 2008; 3: 224-8.

21.

Bhardwaj R. , Ganju N. , Sharma M. , Sud S. , Asotra S. Prevalence of coronary artery disease in patients with symptomatic peripheral vascular disease . Indian Heart J 2001; 53: 189-91.

22.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) . JAMA 2001; 285: 2486-97.

23.

Katzmarzyk PT , Janssen I. , Ross R. , Church TS , Blair SN The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men . Diabetes Care 2006; 29: 404-9.

24.

Sundstrom J. , Riserus U. , Byberg L. , Zethelius B. , Lithell H. , Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 2006; 332: 878-82.

25.

Novo G. , Corrado E. , Muratori I. , et al. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome. Int Angiol 2007; 26(4): 312-7.

26.

Baltali M. , Gokcel A. , Kiziltan HT , et al. Association between the metabolic syndrome and newly diagnosed coronary artery disease. Diabetes Nutr Metab 2003; 16: 169-75.

27.

Noto D. , Barbagallo CM , Cefalù AB , et al. The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population. Atherosclerosis 2008; 197: 147-53.

28.

Ebrahimi M. , Kazemi-Bajestani SM , Ghayour-Mobarhan M. , et al. Metabolic syndrome may not be a good predictor of coronary artery disease in the Iranian population: population-specific definitions are required. ScientificWorldJournal 2009; 14(9): 86-96.

29.

Kahn R. , Buse J. , Ferrannini E. , Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-304.

30.

Reaven GM The metabolic syndrome: requiescat in pace. Clin Chem 2005; 51: 931-8.

31.

Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997; 95: 252-64.

32.

Jousilahti P. , Vartiainen E. , Tuomilehto J. , Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999 ; 99: 1165-72.

33.

Pilote L. , Dasgupta K. , Guru V. , et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007; 176: S1-44.

34.

Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 1998; 351: 1425-7.

35.

Evans A. , Van Baal GC , McCarron P. , et al. The genetics of coronary heart disease: the contribution of twin studies. Twin Res 2003; 6: 432-41.

36.

McCarthy JJ Gene by sex interaction in the etiology of coronary heart disease and the preceding metabolic syndrome. Nutr Metab Cardiovasc Dis 2007; 17: 153-61.

37.

Scott MG Primary prevention of coronary heart disease. Am J Med 1999; 107(Supp): 1-5.

38.

Robertson TL , Kato H. , Rhoads GG , et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: Coronary heart disease risk factors in Japan and Hawaii . Am J Cardiol 1977; 39: 244-9.

39.

Jee SH , Suh I. , Kim IS , Appel LJ Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: The Korea Medical Insurance Corporation Study . JAMA 1999; 282: 2149-55.

40.

Keys A. Seven countries: a multivariate analysis of death and coronary heart disease , Cambridge, MA: Harvard University Press, 1980: 136-60.

41.

Kaplan GA , Keil JE Socioeconomic factors and cardiovascular disease: a review of the literature . Circulation 1993; 88: 1973-98.

42.

Lenfant C. Conference on socioeconomic status and cardiovascular health and disease . Circulation 1996; 94: 2041-4.

43.

DeWalt DA , Berkman ND , Sheridan S. , Lohr KN , Pignone MP Literacy and health outcomes: a systematic review of the literature. J Gen Intern Med 2004; 19: 1228-39.

44.

Leigh JP Direct and indirect effects of education on health. Soc Sci Med 1983; 17: 227-34.